Background Technological advances in surgery, intensive care and medical support have led to substantial decrease in mortality for children with congenital heart defects (CHDs) over the last 50 years. Methods Using routinely-collected mortality and population data for England and Wales from 1959 to 2009, the authors investigated age, period and birth cohort trends in child mortality attributable to CHDs.
INTRODUCTION
Congenital heart defects (CHDs) are one of the most common types of congenital malformation in the UK and, without surgery, often incompatible with long-term survival. The birth prevalence of serious CHDs has remained stable at 6-8 per 1000 live births over several decades, although changes in the ascertainment of mild defects, associated with new technologies such as echocardiography, have been reported. 1 2 Surgical intervention is usually required within the fi rst year of life for serious CHDs; however, technological advances in paediatric cardiac surgery and medical care have led to marked improvements in survival during the last 50 years. 3 Prior to these clinical advances, few children with serious CHDs survived into adulthood. 4 5 Although early surgical techniques were introduced in the 1940s, more recent achievements have included the Mortality with congenital heart defects in England and Wales, 1959 Wales, -2009 : exploring technological change through period and birth cohort analysis Rachel L Knowles, 1 Catherine Bull, 2 Christopher Wren, 3 Carol Dezateux 1 palliative Fontan operation, complete anatomical repair of transposition of the great arteries and the Norwood procedure. Intensive care, anaesthetic and medical therapies have also played a crucial role in supporting the development of complex surgical techniques, particularly for neonates. Despite the rising numbers of paediatric cardiac procedures being undertaken, mortality at 30 days after surgery is decreasing, 6 and the number of UK adults with CHDs is growing by around 1600 per year. 7 Most studies exploring survival with CHDs are surgical case series, thus selectively present outcomes for individuals undergoing cardiac interventions within a single centre; however,
What is already known?
Although infants under 1 year of age remain ▶ at greatest risk of premature death, CHDrelated mortality has declined during the last 30 years. Survival into adulthood is likely for 80% ▶ children with CHDs who survive beyond their fi rst year of life. Death rates are higher in males as compared ▶ with females but sex differences in mortality are decreasing as overall CHD mortality falls.
What this study adds?
Infants comprised 63% of CHD deaths during ▶ 1959-63 but were 22% in 2004-08, coincident with 50 years of advances in neonatal and paediatric cardiac technologies. Death rates have improved for successive ▶ birth cohorts and a continuing decline in child and young adult mortality is predicted for future generations. As paediatric cardiac mortality continues ▶ to fall, exploration of the impact on adult cardiovascular mortality and the implications for future service provision is warranted. 
RESULTS

Number of deaths
Analysis by period of death
The percentages of CHD-related deaths occurring in different age-groups, by period of death, are shown in fi gure 2. Infants comprised over 50% of CHD deaths until the period 1979-1983, but now represent 22% of all CHD deaths (online supplementary table 2). Conversely 21% of CHD deaths between 1959 and 1973 were adults, whereas the majority of deaths now occur within this age-range. Notably two periods of declining infant deaths in 1969-1978 and 1984-1993 , coincident with new surgical techniques in the UK, were associated with temporary increases in deaths in children aged 1 to 14 years.
CHDs were recorded as a cause in 9% (n=1860) of 21 673 child deaths (under age 15 years) in 1959 and in 3% (n=128) of 4570 child deaths occurring in 2008.
Age-standardised death rates
Age-standardised death rates at all ages, including adults and children, were estimated for each sex (fi gure 3). Mortality retrospective cohort studies 8 and smaller regional studies 7 9 have also reported longer-term survival into adulthood with and without surgery. Some authors [10] [11] [12] [13] have examined longerterm changes in mortality for CHDs, using routine data from US (1979-1997; 1999-2006) , UK (1994 UK ( -2003 and Canadian (1987 Canadian ( -2005 populations. While reporting declining overall CHD mortality, they noted signifi cantly higher mortality in groups with severe CHDs, 13 non-white ethnicity 10 11 and males. 11 12 Important infl uences on mortality include physiological ageing, secular (period) trends and birth cohort (generational) effects. Acquired heart disease or the physiological transition from fetal to neonatal circulation can increase the risk of death at specifi c ages. Generational infl uences are due to early life factors affecting individuals born at a similar time and exert a lasting effect. New technologies to correct CHDs in early life or improve prenatal detection might have a cohort effect. Crucially, no population-based birth cohort analyses have fully encompassed the changing CHD-associated mortality over the last 50 years coincident with advances in paediatric cardiac surgery. Understanding mortality within this context of marked technological change is essential to inform future clinical management and service provision for individuals born with CHDs today.
In this paper, we characterise trends in CHD-associated mortality by age and birth cohort, using routine death registrations for England and Wales between 1959 and 2009. Deaths were obtained by year of death with information on calendar year of birth, age at death and sex. To avoid disclosure, data were aggregated into 5-year periods by year of birth and year of death; age at death was aggregated into 5-year intervals except for two age-groups representing death under 1 year (infants) and at 1 to 4 years of age. Children were defi ned as aged up to, but not including, 15 years. Some deaths (n=392), registered with ONS between January and March 1969, had no record of year of birth, although age at death was known. These cases were included in analyses by year of death but not year of birth, and sensitivity analyses were undertaken to estimate the effect of including these cases in analyses by year of birth.
METHODS
Details of deaths in England and
Age and sex-specifi c death rates for each 5-year period were calculated using mid-year population estimates [15] [16] [17] and standardised against the European population to facilitate comparison between time periods. 18 Trends in age-specifi c death rates between 1959 and 2008 were examined for each sex by the year of death and 95% CIs for the age-standardised rate ratio for males and females estimated to determine statistically signifi cant rate differences. 18 19 Trends in age-specifi c death rates between 1959 and 2008 were examined for each birth cohort and future mortality up to age 44 years was predicted using a Poisson regression model based on the observed mortality data. 20 Analyses were undertaken using StataSE V.10 (Timberlake Consulting). 
of rate ratios indicated that males had a statistically signifi cant higher death rate compared with females (data table included in fi gure 3).
During the period 2004-2008, boys continued to have a signifi cantly higher death rate than girls aged under 1 year or 5 to 14 years but no signifi cant sex difference was seen for deaths in children aged 1 to 4 years (online supplementary fi gure S1).
The age-standardised death rate in infants under 1 year has remained signifi cantly higher than for all older age-groups during the past 50 years. During the period 2004-2008, the death rate per 100 000 children aged 1 to 14 years was 0.53 (0.58, 0.48 for boys and girls respectively) compared with 14.70 (15.44, 13.92 for boys and girls respectively) per 100 000 infants aged under 1 year (rate difference 14.17 (95% CI 12.68 to 15.48), p<0.0001).
Birth cohort mortality
Age-standardised death rates (per 100 000 population) were similar for both sexes in successive 5-year birth cohorts (data not shown), therefore fi gure 4 includes all individuals. Within all 5-year birth cohorts since 1959, the highest death rates were experienced by infants under 1 year of age. Death rates in children under 1 year and over 5 years of age have improved for successive birth cohorts; however, improvement was greater for cohorts born after 1988. In early birth cohorts, there was no reduction in mortality within the age-group 1 to 4 years, which may be due to advances in neonatal care resulting in prolonged survival beyond infancy but with death occurring in the second to fi fth years of life. The most recent birth cohorts, representing children born between 1989 and 2008, demonstrate appreciably lower death rates across all age-groups than previously reported.
The uninterrupted lines in fi gure 4 indicate observed data points; these have been extended by interrupted lines to indicate predicted death rates using a Poisson regression model. These models suggest that improvements in mortality could continue for future generations although further follow-up will be needed to confi rm these predictions.
In comparison with the birth cohort from 1959 to 1963, there has been a decline in mortality across all 'age at death' groups for individuals born during [2004] [2005] [2006] [2007] [2008] . Mortality under 1 year decreased for successive birth cohorts (fi gure 5), more dramatically after the period 1979-1983, whereas mortality at 1 to 4 years old increased in cohorts born before the period 1984-1988 then declined. These changes most likely refl ect advances in neonatal management leading to decreased infant mortality in the 1980s but for some children death was only delayed.
DISCUSSION
This paper presents the fi rst age-period-cohort analysis to explore long-term trends in population death rates for individuals with CHDs in England and Wales. We describe changes in mortality extending back over fi ve decades during which major advances in paediatric cardiac surgery and intensive care have dramatically altered the survival outlook for affected individuals.
Since Age-standardised death rates for CHDs have declined steadily for both sexes yet, despite a narrowing of the sex difference, males continue to have signifi cantly higher death rates than females. Analysis of generational infl uences indicates that death rates have improved for each successive birth cohort, particularly for those born since 1989, and a Poisson regression model based on these observations predicts a continuing decline in mortality.
Temporal trends in population-based mortality with CHDs have previously been reported, 10 12 13 including demonstration of increasing age at death for some individual defects. Death rates estimated in our study, for successive time periods, are largely consistent with the previous fi ndings although, unlike Billett, 12 we found statistically signifi cant sex differences persisting after 2004. However, our study data extend over a longer period of changing clinical management, thus permitting analyses of generational effects infl uencing CHD-related mortality.
Routine death registrations are a reliable source of population-based data, providing suffi cient numbers for precise estimation of secular trends. However, birth cohort death rates in our study could not be extrapolated beyond 44 years of age due to the small number of observed deaths after this age. Deaths were aggregated across diagnostic groups and into 5-year agebands to avoid the risk of identifying individuals, but this prevented comparisons between individual CHDs. Finally in the dataset provided by ONS, the birth year was missing for deaths in the fi rst quarter of 1969. To address this, we undertook sensitivity analyses including these additional deaths, the results of which supported our original fi ndings.
A key concern relating to routine data is the potential for misclassifi cation by the cause of death. The Central Cardiac Audit Database recorded 126 deaths in children within 1 year of surgery performed during 2008-2009 within English and Welsh centres, 6 slightly higher than the fi gure of 97 infant deaths recorded within our routine mortality dataset for 2009. This may refl ect under-reporting of CHDs on death certifi cates for children who die of non-cardiac causes, such as prematurity. Some deaths in older adults may also refl ect misclassifi cation of acquired cardiac disease, for example, valve disease or acquired complications of congenital variants, thus infl ating the number of deaths attributed to CHDs in these age-groups. However, these reasons for underascertainment do not vary between time periods so should not infl uence the secular trends reported here.
It is also possible that misclassifi cation occurred during periods of transition between coding systems, as four versions of the ICD were used. Although such effects are known to occur, 21 there was no evidence of discontinuity in our data (data not shown) and other authors have similarly failed to fi nd any evidence of coding change infl uencing CHD death rates. 12 Age-standardised death rates were highest for infants under the age of 1 year at all time periods. As children with CHDs survived infancy and into later childhood, our data show that falls in infant mortality in 1964-1973 and 1979-1993 were accompanied by rise in mortality at age 1 to 4 years. This suggests that a proportion of infants survived the fi rst year of life but died before reaching school-age. Notably since 1989, the decline in infant deaths has been accompanied by a sustained decrease in deaths at all ages throughout childhood which may indicate that neonatal interventions now have greater capacity to prolong survival with CHDs and is consistent with reports of a growing adult population with CHDs. 7 Interestingly, falls in infant mortality in the 1970s and 1980s appear coincident with the wider use of cardiopulmonary bypass and introduction of prostaglandin infusions to support infants prior to surgery. Continuing reductions in death rates may refl ect the increasing preference for primary neonatal surgical repair, such as the arterial switch operation. 22 Prenatal detection of CHDs, providing parents with choice about termination of an affected pregnancy, also infl uences mortality with CHDs as it results in disproportionate termination of fetuses with more severe defects, such as hypoplastic left heart or univentricular hearts. [23] [24] [25] [26] If pregnancies affected by these severe defects are terminated then the spectrum of defects at term will include fewer life-threatening defects for which palliative terminal care (without intervention) is more likely to be chosen by parents. Mortality in the fi rst year of life would therefore appear to be lower because these children would no longer appear within the routine postnatal death data used here. Abortion statistics for England and Wales demonstrate that around 100-150 abortions are undertaken each year because of cardiovascular malformations in the fetus. 27 Prenatal screening, though available in the UK for three decades, demonstrates differences in regional detection rates and the probability of detection for different defects. 23 25 Follow-up of recent birth cohorts are too limited to assess the true impact on adult mortality of contemporary management of CHDs, particularly as those currently reaching older ages are likely to be the 'healthy survivors' from early birth cohorts. This is the fi rst UK study to explore both age and birth cohort trends in CHD-related death rates throughout the fi ve decades during which major innovations in medical, surgical and intensive care have dramatically altered the outlook for affected individuals in Europe and North America. Our data clearly refl ect the shift in the burden of CHD mortality from infancy to early childhood but demonstrate that this was initially accompanied by a rise in deaths between 1 and 4 years, It is signifi cant that reduced mortality has only been realised across all child age-groups for births since 1989 and that sex differences in death rates still persist.
Crucially, the decline in CHD-related mortality in children and young adults born in the most recent decade shows no signs of stabilising; however, further observation of more recent birth cohorts is warranted to confi rm these trends and to explore the impact on late adult mortality of extended childhood survival with CHDs.
